s6y
Company name or ticker
Search
Orexigen Therapeutics, Inc.
4
Lynch Thomas P.: Statement of changes in beneficial ownership of securities
Filed
Wednesday, December 2, 2015
Period
Dec 1, 2015
Accession number
0001209191-15-083003
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header